KA
TMO icon

Klingman & Associates’s Thermo Fisher Scientific TMO Stock Holding History

Klingman & Associates’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$956K Buy
1,944
+65
+3% +$35.3K 0.05% 133
2025
Q4 		$1.09M Buy
1,879
+30
+2% +$17K 0.05% 126
2025
Q3 		$897K Buy
1,849
+184
+11% +$85.6K 0.05% 128
2025
Q2 		$675K Buy
1,665
+120
+8% +$50.2K 0.04% 141
2025
Q1 		$769K Sell
1,545
-642
-29% -$348K 0.05% 119
2024
Q4 		$1.14M Sell
2,187
-950
-30% -$522K 0.07% 96
2024
Q3 		$1.94M Buy
3,137
+2,353
+300% +$1.39M 0.12% 75
2024
Q2 		$434K Buy
784
+232
+42% +$133K 0.03% 151
2024
Q1 		$321K Buy
552
+28
+5% +$15.7K 0.02% 187
2023
Q4 		$278K Sell
524
-59
-10% -$28.6K 0.02% 190
2023
Q3 		$295K Buy
583
+144
+33% +$76.7K 0.02% 181
2023
Q2 		$229K Buy
439
+21
+5% +$11.3K 0.02% 197
2023
Q1 		$241K Sell
418
-13
-3% -$7.33K 0.02% 176
2022
Q4 		$237K Buy
+431
New +$228K 0.02% 179
2022
Q3 		– Sell
-369
Closed -$200K – 201
2022
Q2 		$200K Buy
369
+11
+3% +$6.05K 0.02% 188
2022
Q1 		$211K Sell
358
-44
-11% -$25.3K 0.02% 196
2021
Q4 		$268K Buy
+402
New +$251K 0.02% 153
2016
Q4 		– Sell
-691
Closed -$110K – 292
2016
Q3 		$110K Hold
691
– – 0.03% 131
2016
Q2 		$102K Hold
691
– – 0.03% 139
2016
Q1 		$98K Sell
691
-1,675
-71% -$224K 0.04% 144
2015
Q4 		$336K Hold
2,366
– – 0.13% 78
2015
Q3 		$289K Buy
2,366
+1,675
+242% +$218K 0.11% 84
2015
Q2 		$90K Hold
691
– – 0.04% 140
2015
Q1 		$93K Hold
691
– – 0.04% 134
2014
Q4 		$86K Buy
+691
New +$84K 0.04% 140

Other funds holding TMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Klingman & Associates's TMO Position: Q1 2026 in Review

Klingman & Associates increased its Thermo Fisher Scientific (TMO) stake by 3.5% in Q1 2026, buying an estimated $35.3K and bringing the position to 1,944 shares worth $956K. The position accounts for 0.05% of the portfolio, ranked #133.

Klingman & Associates first reported a position in TMO in Q4 2014 and has held it in 25 quarters since. The position peaked at $1.94M in Q3 2024. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

  • Klingman & Associates held 1,944 shares of Thermo Fisher Scientific worth $956K as of Q1 2026.
  • Klingman & Associates bought 65 Thermo Fisher Scientific shares in Q1 2026, an estimated $35.3K.
  • Thermo Fisher Scientific made up 0.05% of Klingman & Associates's portfolio in Q1 2026, its #133 holding.
  • Klingman & Associates first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 25 quarters since.
  • Klingman & Associates's Thermo Fisher Scientific position peaked at $1.94M in Q3 2024.
  • 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Klingman & Associates's 13F filing for Q1 2026, filed 14 May 2026.